US Patent Office Allows Patent Claims for Intellectual Property Exclusively Licensed to Renalytix
LONDON and SALT LAKE CITY, Oct. 06, 2023 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX), the first company...
LONDON and SALT LAKE CITY, Oct. 06, 2023 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX), the first company...
This press release replaces the one issued on October 5, 2023 at 2:35 PM ET, correcting brand guidelines.SCOTTSDALE, AZ /...
Technology-powered collaboration aims to deliver AI-enabled devices and digital solutions at the enterprise level to increase clinical and operational efficiencies,...
SCOTTSDALE, AZ / ACCESSWIRE / October 5, 2023 / Magnolia Point, a leading innovator in digital healthcare AI solutions, is...
Senzo Health Limited (London, UK) ("Senzo"), a life sciences company developing high-accuracy, low-cost, point-of-care diagnostic technologies, this week announced an...
ANN ARBOR, MI / ACCESSWIRE / October 5, 2023 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary...
Women's health & diagnostics veteran to lead company's growthSALINAS, CA / ACCESSWIRE / October 4, 2023 / OncoGenesis, Inc. ("OncoGenesis")...
The integration paves the way for simplified access to Lifescan suite of diagnostic services for telehealth and traditional care providers.SKOKIE,...
HENDERSON, NV / ACCESSWIRE / September 28, 2023 / Luventix Inc., a development-stage company pioneering Intelligent Disease Diagnostics using Artificial...
Combined company aims to accelerate precision, personalized medicine for longevity powered by mutually reinforcing AI and biotechnology platforms for early...
Highlights include the company’s strong foundation for growth, focus on innovation and attractive long-term outlookSAN DIEGO, Sept. 29, 2023 (GLOBE...
Meetings with Growth-Oriented Investors, September 29 to October 1, 2023MISSISSAUGA, Ontario, Sept. 29, 2023 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc....
TORONTO and CALGARY, Alberta, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Biosenta Inc. (“Biosenta” or the “Company”) (CSE: ZRO) is thrilled...
Provides Initial $59 Million and up to $168 Million Contingent on MilestonesNATICK, Mass., Sept. 28, 2023 (GLOBE NEWSWIRE) -- ModeX...
AI-driven literature extraction for thousands of rare disease genes fortifies and extends QIAGEN’s proprietary, human-certified content, providing complete bibliographic coverage...
EDMONTON, Alberta--(BUSINESS WIRE)--BioAlberta has published its 2023 State of the Industry (SOI) report. This year’s report includes new insights and...
New customer orders received in Q3 exceed $1M annualized revenueNEW HAVEN, Conn., Sept. 28, 2023 (GLOBE NEWSWIRE) -- Specialty cancer...
Tunisian Society of Nephrology first professional body in the field to publish nationwide guidanceAssociation of specialists recommends national immune response...
LONDON and SALT LAKE CITY, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial intelligence-enabled...
HALIFAX, NS / ACCESSWIRE / September 27, 2023 / Today, MedMira Inc. (MedMira) (TSXV:MIR) provides an update on its progress...